nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—CHRM2—type 1 diabetes mellitus	0.918	1	CbGaD
Quinidine barbiturate—Quinine—CHRM2—type 1 diabetes mellitus	0.00308	0.532	CrCbGaD
Quinidine barbiturate—Quinidine—CHRM2—type 1 diabetes mellitus	0.0027	0.468	CrCbGaD
Quinidine barbiturate—Laryngospasm—Ramipril—type 1 diabetes mellitus	0.00233	0.0331	CcSEcCtD
Quinidine barbiturate—Liver injury—Ramipril—type 1 diabetes mellitus	0.00206	0.0294	CcSEcCtD
Quinidine barbiturate—Hearing impaired—Ramipril—type 1 diabetes mellitus	0.00183	0.0259	CcSEcCtD
Quinidine barbiturate—Hepatocellular injury—Ramipril—type 1 diabetes mellitus	0.00174	0.0247	CcSEcCtD
Quinidine barbiturate—Photosensitivity—Ramipril—type 1 diabetes mellitus	0.00144	0.0204	CcSEcCtD
Quinidine barbiturate—Deafness—Ramipril—type 1 diabetes mellitus	0.00141	0.02	CcSEcCtD
Quinidine barbiturate—Haemolytic anaemia—Ramipril—type 1 diabetes mellitus	0.0014	0.0199	CcSEcCtD
Quinidine barbiturate—Renal failure acute—Ramipril—type 1 diabetes mellitus	0.00137	0.0194	CcSEcCtD
Quinidine barbiturate—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.00134	0.019	CcSEcCtD
Quinidine barbiturate—Renal impairment—Ramipril—type 1 diabetes mellitus	0.00133	0.0188	CcSEcCtD
Quinidine barbiturate—Purpura—Ramipril—type 1 diabetes mellitus	0.00131	0.0186	CcSEcCtD
Quinidine barbiturate—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.00129	0.0184	CcSEcCtD
Quinidine barbiturate—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00116	0.0166	CcSEcCtD
Quinidine barbiturate—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.00115	0.0164	CcSEcCtD
Quinidine barbiturate—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.00115	0.0164	CcSEcCtD
Quinidine barbiturate—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00114	0.0162	CcSEcCtD
Quinidine barbiturate—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.00114	0.0161	CcSEcCtD
Quinidine barbiturate—Asthma—Ramipril—type 1 diabetes mellitus	0.00109	0.0155	CcSEcCtD
Quinidine barbiturate—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.00107	0.0152	CcSEcCtD
Quinidine barbiturate—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00106	0.0151	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.00104	0.0147	CcSEcCtD
Quinidine barbiturate—Neutropenia—Ramipril—type 1 diabetes mellitus	0.00102	0.0145	CcSEcCtD
Quinidine barbiturate—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.000995	0.0141	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.000964	0.0137	CcSEcCtD
Quinidine barbiturate—Renal failure—Ramipril—type 1 diabetes mellitus	0.000955	0.0136	CcSEcCtD
Quinidine barbiturate—Jaundice—Ramipril—type 1 diabetes mellitus	0.000947	0.0135	CcSEcCtD
Quinidine barbiturate—Sweating—Ramipril—type 1 diabetes mellitus	0.000932	0.0132	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.000907	0.0129	CcSEcCtD
Quinidine barbiturate—Hepatitis—Ramipril—type 1 diabetes mellitus	0.000873	0.0124	CcSEcCtD
Quinidine barbiturate—Visual impairment—Ramipril—type 1 diabetes mellitus	0.000841	0.012	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.000825	0.0117	CcSEcCtD
Quinidine barbiturate—Tinnitus—Ramipril—type 1 diabetes mellitus	0.000814	0.0116	CcSEcCtD
Quinidine barbiturate—Flushing—Ramipril—type 1 diabetes mellitus	0.00081	0.0115	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.000788	0.0112	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.000786	0.0112	CcSEcCtD
Quinidine barbiturate—Mental disorder—Ramipril—type 1 diabetes mellitus	0.000764	0.0109	CcSEcCtD
Quinidine barbiturate—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00076	0.0108	CcSEcCtD
Quinidine barbiturate—Erythema—Ramipril—type 1 diabetes mellitus	0.00076	0.0108	CcSEcCtD
Quinidine barbiturate—Tension—Ramipril—type 1 diabetes mellitus	0.000745	0.0106	CcSEcCtD
Quinidine barbiturate—Nervousness—Ramipril—type 1 diabetes mellitus	0.000738	0.0105	CcSEcCtD
Quinidine barbiturate—Tremor—Ramipril—type 1 diabetes mellitus	0.000712	0.0101	CcSEcCtD
Quinidine barbiturate—Agitation—Ramipril—type 1 diabetes mellitus	0.000698	0.00992	CcSEcCtD
Quinidine barbiturate—Angioedema—Ramipril—type 1 diabetes mellitus	0.000694	0.00987	CcSEcCtD
Quinidine barbiturate—Vertigo—Ramipril—type 1 diabetes mellitus	0.000682	0.0097	CcSEcCtD
Quinidine barbiturate—Syncope—Ramipril—type 1 diabetes mellitus	0.000681	0.00968	CcSEcCtD
Quinidine barbiturate—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00068	0.00967	CcSEcCtD
Quinidine barbiturate—Palpitations—Ramipril—type 1 diabetes mellitus	0.000671	0.00954	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.000668	0.00949	CcSEcCtD
Quinidine barbiturate—Convulsion—Ramipril—type 1 diabetes mellitus	0.000658	0.00936	CcSEcCtD
Quinidine barbiturate—Arthralgia—Ramipril—type 1 diabetes mellitus	0.000647	0.00919	CcSEcCtD
Quinidine barbiturate—Myalgia—Ramipril—type 1 diabetes mellitus	0.000647	0.00919	CcSEcCtD
Quinidine barbiturate—Chest pain—Ramipril—type 1 diabetes mellitus	0.000647	0.00919	CcSEcCtD
Quinidine barbiturate—Anxiety—Ramipril—type 1 diabetes mellitus	0.000644	0.00916	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.000642	0.00913	CcSEcCtD
Quinidine barbiturate—Confusional state—Ramipril—type 1 diabetes mellitus	0.000625	0.00889	CcSEcCtD
Quinidine barbiturate—Oedema—Ramipril—type 1 diabetes mellitus	0.00062	0.00881	CcSEcCtD
Quinidine barbiturate—Shock—Ramipril—type 1 diabetes mellitus	0.00061	0.00867	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.000608	0.00864	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.000607	0.00863	CcSEcCtD
Quinidine barbiturate—Tachycardia—Ramipril—type 1 diabetes mellitus	0.000605	0.0086	CcSEcCtD
Quinidine barbiturate—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000602	0.00856	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.000599	0.00852	CcSEcCtD
Quinidine barbiturate—Anorexia—Ramipril—type 1 diabetes mellitus	0.000591	0.0084	CcSEcCtD
Quinidine barbiturate—Hypotension—Ramipril—type 1 diabetes mellitus	0.000579	0.00823	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.000565	0.00803	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.000553	0.00786	CcSEcCtD
Quinidine barbiturate—Somnolence—Ramipril—type 1 diabetes mellitus	0.000551	0.00783	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000539	0.00766	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000535	0.00761	CcSEcCtD
Quinidine barbiturate—Constipation—Ramipril—type 1 diabetes mellitus	0.00053	0.00754	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.000511	0.00726	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000507	0.00721	CcSEcCtD
Quinidine barbiturate—Urticaria—Ramipril—type 1 diabetes mellitus	0.000492	0.007	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00049	0.00697	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00049	0.00697	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.000457	0.00649	CcSEcCtD
Quinidine barbiturate—Asthenia—Ramipril—type 1 diabetes mellitus	0.000445	0.00632	CcSEcCtD
Quinidine barbiturate—Pruritus—Ramipril—type 1 diabetes mellitus	0.000439	0.00623	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000424	0.00603	CcSEcCtD
Quinidine barbiturate—Dizziness—Ramipril—type 1 diabetes mellitus	0.00041	0.00583	CcSEcCtD
Quinidine barbiturate—Vomiting—Ramipril—type 1 diabetes mellitus	0.000394	0.0056	CcSEcCtD
Quinidine barbiturate—Rash—Ramipril—type 1 diabetes mellitus	0.000391	0.00556	CcSEcCtD
Quinidine barbiturate—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000391	0.00555	CcSEcCtD
Quinidine barbiturate—KCNK1—Potassium Channels—ABCC8—type 1 diabetes mellitus	0.00039	0.0716	CbGpPWpGaD
Quinidine barbiturate—Headache—Ramipril—type 1 diabetes mellitus	0.000388	0.00552	CcSEcCtD
Quinidine barbiturate—Nausea—Ramipril—type 1 diabetes mellitus	0.000368	0.00523	CcSEcCtD
Quinidine barbiturate—KCNK1—Potassium Channels—KCNJ11—type 1 diabetes mellitus	0.000308	0.0566	CbGpPWpGaD
Quinidine barbiturate—KCNK1—Neuronal System—ABCC8—type 1 diabetes mellitus	0.00017	0.0312	CbGpPWpGaD
Quinidine barbiturate—KCNK1—Neuronal System—GAD2—type 1 diabetes mellitus	0.000149	0.0273	CbGpPWpGaD
Quinidine barbiturate—KCNK1—Neuronal System—KCNJ11—type 1 diabetes mellitus	0.000135	0.0247	CbGpPWpGaD
Quinidine barbiturate—KCNK1—Neuronal System—SLC18A2—type 1 diabetes mellitus	0.00013	0.0239	CbGpPWpGaD
Quinidine barbiturate—KCNK1—Neuronal System—GAD1—type 1 diabetes mellitus	0.000129	0.0237	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Potassium Channels—ABCC8—type 1 diabetes mellitus	0.000118	0.0216	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Hematopoietic Stem Cell Differentiation—VAV1—type 1 diabetes mellitus	0.000111	0.0204	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Potassium Channels—KCNJ11—type 1 diabetes mellitus	9.3e-05	0.0171	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Cardiac Progenitor Differentiation—IGF2—type 1 diabetes mellitus	8.27e-05	0.0152	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Monoamine GPCRs—ADRB1—type 1 diabetes mellitus	8.23e-05	0.0151	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Amine ligand-binding receptors—ADRB1—type 1 diabetes mellitus	6.91e-05	0.0127	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—GAD2—type 1 diabetes mellitus	6.63e-05	0.0122	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—CHRM2—type 1 diabetes mellitus	6.27e-05	0.0115	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—FGF21—type 1 diabetes mellitus	6.21e-05	0.0114	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—CHRM2—type 1 diabetes mellitus	6.08e-05	0.0112	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—ABCC8—type 1 diabetes mellitus	5.82e-05	0.0107	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—SLC18A2—type 1 diabetes mellitus	5.81e-05	0.0107	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—CACNA1G—type 1 diabetes mellitus	5.77e-05	0.0106	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—GAD1—type 1 diabetes mellitus	5.75e-05	0.0106	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Melatonin metabolism and effects—ADRB1—type 1 diabetes mellitus	5.51e-05	0.0101	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Cardiac Progenitor Differentiation—INS—type 1 diabetes mellitus	5.49e-05	0.0101	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Cardiac Progenitor Differentiation—IGF1—type 1 diabetes mellitus	5.31e-05	0.00975	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—ABCC8—type 1 diabetes mellitus	5.14e-05	0.00943	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—GAD2—type 1 diabetes mellitus	5.08e-05	0.00933	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Hematopoietic Stem Cell Differentiation—IL1B—type 1 diabetes mellitus	4.97e-05	0.00913	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—GAD2—type 1 diabetes mellitus	4.67e-05	0.00857	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—SST—type 1 diabetes mellitus	4.62e-05	0.00849	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—KCNJ11—type 1 diabetes mellitus	4.6e-05	0.00844	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—GAD2—type 1 diabetes mellitus	4.49e-05	0.00824	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—SST—type 1 diabetes mellitus	4.48e-05	0.00822	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—SLC18A2—type 1 diabetes mellitus	4.45e-05	0.00817	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—GAD1—type 1 diabetes mellitus	4.41e-05	0.00809	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	4.19e-05	0.00769	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—CHRM2—type 1 diabetes mellitus	4.13e-05	0.00758	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—PAX4—type 1 diabetes mellitus	4.12e-05	0.00755	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—CACNA1G—type 1 diabetes mellitus	4.12e-05	0.00755	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—ABCC8—type 1 diabetes mellitus	4.09e-05	0.00752	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—SLC18A2—type 1 diabetes mellitus	4.09e-05	0.00751	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—KCNJ11—type 1 diabetes mellitus	4.06e-05	0.00745	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—GAD1—type 1 diabetes mellitus	4.05e-05	0.00743	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—GAD2—type 1 diabetes mellitus	3.98e-05	0.00731	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—SLC18A2—type 1 diabetes mellitus	3.93e-05	0.00722	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—GAD1—type 1 diabetes mellitus	3.89e-05	0.00715	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—GAD2—type 1 diabetes mellitus	3.58e-05	0.00657	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	3.57e-05	0.00656	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—PDX1—type 1 diabetes mellitus	3.5e-05	0.00642	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—HNF1A—type 1 diabetes mellitus	3.5e-05	0.00642	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—ABCC8—type 1 diabetes mellitus	3.49e-05	0.00641	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—SLC18A2—type 1 diabetes mellitus	3.49e-05	0.0064	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—GAD1—type 1 diabetes mellitus	3.45e-05	0.00634	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—IL10—type 1 diabetes mellitus	3.29e-05	0.00605	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—KCNJ11—type 1 diabetes mellitus	3.24e-05	0.00594	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—IL10—type 1 diabetes mellitus	3.19e-05	0.00586	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—SLC18A2—type 1 diabetes mellitus	3.13e-05	0.00575	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—GAD1—type 1 diabetes mellitus	3.1e-05	0.0057	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—GAD2—type 1 diabetes mellitus	3.05e-05	0.0056	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—SST—type 1 diabetes mellitus	3.05e-05	0.00559	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—ITPR3—type 1 diabetes mellitus	3.01e-05	0.00553	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—type 1 diabetes mellitus	2.91e-05	0.00535	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—KCNJ11—type 1 diabetes mellitus	2.76e-05	0.00507	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—SLC18A2—type 1 diabetes mellitus	2.67e-05	0.00491	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—GAD1—type 1 diabetes mellitus	2.65e-05	0.00486	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	2.54e-05	0.00466	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—GAL—type 1 diabetes mellitus	2.51e-05	0.0046	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—CCL20—type 1 diabetes mellitus	2.48e-05	0.00455	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB1—type 1 diabetes mellitus	2.46e-05	0.00452	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—SST—type 1 diabetes mellitus	2.38e-05	0.00438	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Other—CCR5—type 1 diabetes mellitus	2.36e-05	0.00434	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—PRKCQ—type 1 diabetes mellitus	2.21e-05	0.00406	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	2.2e-05	0.00404	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—IL10—type 1 diabetes mellitus	2.17e-05	0.00398	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	2.17e-05	0.00397	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—PRKCQ—type 1 diabetes mellitus	2.12e-05	0.0039	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—IAPP—type 1 diabetes mellitus	2.09e-05	0.00384	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—VAV1—type 1 diabetes mellitus	2.06e-05	0.00378	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—CASP3—type 1 diabetes mellitus	2.02e-05	0.0037	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	1.99e-05	0.00366	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	1.97e-05	0.00362	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	1.97e-05	0.00362	CbGpPWpGaD
Quinidine barbiturate—SCN5A—L1CAM interactions—EGFR—type 1 diabetes mellitus	1.94e-05	0.00356	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	1.88e-05	0.00345	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—IL1B—type 1 diabetes mellitus	1.73e-05	0.00317	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—CASP3—type 1 diabetes mellitus	1.72e-05	0.00316	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—SST—type 1 diabetes mellitus	1.72e-05	0.00315	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—IL10—type 1 diabetes mellitus	1.7e-05	0.00312	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—STAT3—type 1 diabetes mellitus	1.69e-05	0.00311	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	1.69e-05	0.00309	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—IL1B—type 1 diabetes mellitus	1.67e-05	0.00307	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—CASP3—type 1 diabetes mellitus	1.67e-05	0.00307	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	1.59e-05	0.00291	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—PRKCQ—type 1 diabetes mellitus	1.58e-05	0.00289	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	1.55e-05	0.00285	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	1.54e-05	0.00282	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—GAL—type 1 diabetes mellitus	1.52e-05	0.00279	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CCL20—type 1 diabetes mellitus	1.5e-05	0.00275	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CCL11—type 1 diabetes mellitus	1.5e-05	0.00275	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—GSTT1—type 1 diabetes mellitus	1.49e-05	0.00273	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	1.44e-05	0.00264	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—CXCL10—type 1 diabetes mellitus	1.43e-05	0.00262	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	1.37e-05	0.00251	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	1.36e-05	0.0025	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	1.32e-05	0.00243	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	1.31e-05	0.00241	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	1.25e-05	0.0023	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	1.22e-05	0.00223	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—IAPP—type 1 diabetes mellitus	1.18e-05	0.00217	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—TYK2—type 1 diabetes mellitus	1.15e-05	0.00212	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—IL1B—type 1 diabetes mellitus	1.14e-05	0.00209	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—CASP3—type 1 diabetes mellitus	1.14e-05	0.00208	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	1.14e-05	0.00208	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—CCR5—type 1 diabetes mellitus	1.11e-05	0.00203	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—SST—type 1 diabetes mellitus	1.04e-05	0.00191	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	1.04e-05	0.0019	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—CDK4—type 1 diabetes mellitus	1.03e-05	0.0019	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	1.03e-05	0.00189	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	1.01e-05	0.00186	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	9.81e-06	0.0018	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—GCG—type 1 diabetes mellitus	9.27e-06	0.0017	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—INS—type 1 diabetes mellitus	9.21e-06	0.00169	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—IL1B—type 1 diabetes mellitus	8.91e-06	0.00164	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—CASP3—type 1 diabetes mellitus	8.89e-06	0.00163	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	8.8e-06	0.00162	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	8.64e-06	0.00159	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GAL—type 1 diabetes mellitus	8.58e-06	0.00157	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	8.48e-06	0.00156	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	8.26e-06	0.00152	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—TYK2—type 1 diabetes mellitus	8.23e-06	0.00151	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GAL—type 1 diabetes mellitus	7.79e-06	0.00143	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCL20—type 1 diabetes mellitus	7.7e-06	0.00141	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCL11—type 1 diabetes mellitus	7.7e-06	0.00141	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—EGFR—type 1 diabetes mellitus	7.34e-06	0.00135	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	7.16e-06	0.00131	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—EGFR—type 1 diabetes mellitus	7.04e-06	0.00129	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CCR5—type 1 diabetes mellitus	6.7e-06	0.00123	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	6.7e-06	0.00123	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	6.67e-06	0.00122	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	6.5e-06	0.00119	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	6.47e-06	0.00119	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IAPP—type 1 diabetes mellitus	6.08e-06	0.00112	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—SST—type 1 diabetes mellitus	5.88e-06	0.00108	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	5.85e-06	0.00107	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—STAT3—type 1 diabetes mellitus	5.76e-06	0.00106	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—IL6—type 1 diabetes mellitus	5.64e-06	0.00103	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	5.54e-06	0.00102	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—SST—type 1 diabetes mellitus	5.34e-06	0.00098	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	5.31e-06	0.000975	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GCG—type 1 diabetes mellitus	5.24e-06	0.000962	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—EGFR—type 1 diabetes mellitus	5.23e-06	0.000961	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	5.22e-06	0.000958	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HBA2—type 1 diabetes mellitus	5.1e-06	0.000936	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	5.04e-06	0.000926	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—TNF—type 1 diabetes mellitus	4.99e-06	0.000915	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	4.9e-06	0.000899	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	4.88e-06	0.000897	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—G6PC2—type 1 diabetes mellitus	4.79e-06	0.00088	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GCG—type 1 diabetes mellitus	4.76e-06	0.000873	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	4.72e-06	0.000867	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GAL—type 1 diabetes mellitus	4.6e-06	0.000844	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	4.58e-06	0.000841	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCL20—type 1 diabetes mellitus	4.55e-06	0.000835	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCL11—type 1 diabetes mellitus	4.55e-06	0.000835	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—VAV1—type 1 diabetes mellitus	4.45e-06	0.000816	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	4.44e-06	0.000814	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ABCC8—type 1 diabetes mellitus	4.16e-06	0.000763	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—IL6—type 1 diabetes mellitus	4.02e-06	0.000738	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ITPR3—type 1 diabetes mellitus	3.84e-06	0.000705	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	3.79e-06	0.000695	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	3.73e-06	0.000685	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SH2B3—type 1 diabetes mellitus	3.61e-06	0.000663	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IAPP—type 1 diabetes mellitus	3.59e-06	0.000659	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—APOC3—type 1 diabetes mellitus	3.59e-06	0.000659	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCR5—type 1 diabetes mellitus	3.44e-06	0.000631	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	3.39e-06	0.000622	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	3.29e-06	0.000603	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SST—type 1 diabetes mellitus	3.15e-06	0.000579	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ADRB1—type 1 diabetes mellitus	3.14e-06	0.000576	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GCG—type 1 diabetes mellitus	2.81e-06	0.000516	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	2.77e-06	0.000509	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2.71e-06	0.000497	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.63e-06	0.000482	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.62e-06	0.000481	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	2.61e-06	0.000479	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	2.59e-06	0.000476	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	2.55e-06	0.000468	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	2.39e-06	0.000438	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.38e-06	0.000437	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CD86—type 1 diabetes mellitus	2.29e-06	0.000421	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	2.19e-06	0.000402	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—E2F1—type 1 diabetes mellitus	2.17e-06	0.000399	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	2.07e-06	0.000379	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCR5—type 1 diabetes mellitus	2.03e-06	0.000373	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	2.03e-06	0.000373	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	2e-06	0.000368	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.99e-06	0.000365	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	1.72e-06	0.000315	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CD80—type 1 diabetes mellitus	1.67e-06	0.000307	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—INS—type 1 diabetes mellitus	1.58e-06	0.00029	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.53e-06	0.00028	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.52e-06	0.000279	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.41e-06	0.000259	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.39e-06	0.000254	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.18e-06	0.000216	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL2—type 1 diabetes mellitus	1.17e-06	0.000215	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.17e-06	0.000214	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	1.14e-06	0.000209	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	1.05e-06	0.000192	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	1e-06	0.000184	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—STAT3—type 1 diabetes mellitus	9.88e-07	0.000181	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EGFR—type 1 diabetes mellitus	8.98e-07	0.000165	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL6—type 1 diabetes mellitus	6.9e-07	0.000127	CbGpPWpGaD
